(Corrects profit increase to 57.6 pct from 62 percent in paragraph 1)
MUMBAI (Reuters) - Lupin Ltd, India's third-largest drugmaker by sales, reported a 57.6 percent jump in quarterly profit, but missed analysts' expectations.
The Mumbai-based company, founded by billionaire Desh Bandhu Gupta, said net profit rose to 6.62 billion rupees ($99.62 million) from 4.20 billion rupees a year earlier.
That compares with an average estimate of a 7.16 billion rupees profit drawn from analysts polled by Thomson Reuters I/B/E/S.
($1 = 66.4500 Indian rupees)
(Reporting by Zeba Siddiqui in Mumbai; Editing by Edwina Gibbs and Subhranshu Sahu)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app